生存率-话题@MedSci

#生存率#

482篇内容 | 6594人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256873, encodeId=de8212568e342, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Dig Liver Dis：血清胆固醇水平可以预测接受经颈静脉肝内门体分流术的肝硬化患者的无移植生存率, objectType=article, longId=292945, objectId=a5ae29294555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5ae29294555, replyNumber=0, likeNumber=143, createdTime=2021-12-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5ae29294555, moduleTitle=Dig Liver Dis：血清胆固醇水平可以预测接受经颈静脉肝内门体分流术的肝硬化患者的无移植生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5ae29294555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256871, encodeId=76b912568e12d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ARD: 法国系统性红斑狼疮住院患者COVID-19相关器官衰竭后的生存率：一项全国性研究, objectType=article, longId=292244, objectId=b2242922445f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2242922445f, replyNumber=0, likeNumber=121, createdTime=2021-12-21, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2242922445f, moduleTitle=ARD: 法国系统性红斑狼疮住院患者COVID-19相关器官衰竭后的生存率：一项全国性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2242922445f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256870, encodeId=79d712568e033, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：多发性硬化症患者结直肠癌生存率, objectType=article, longId=291940, objectId=df332919402b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df332919402b, replyNumber=0, likeNumber=79, createdTime=2021-12-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df332919402b, moduleTitle=Neurology：多发性硬化症患者结直肠癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df332919402b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256868, encodeId=133a1256868f3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Thromb Haemost：噬血细胞性淋巴组织细胞增生症成人出血和血栓栓塞发生率及其对总生存率的影响, objectType=article, longId=221750, objectId=581a221e5012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=581a221e5012, replyNumber=0, likeNumber=138, createdTime=2021-12-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=581a221e5012, moduleTitle=J Thromb Haemost：噬血细胞性淋巴组织细胞增生症成人出血和血栓栓塞发生率及其对总生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=581a221e5012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256869, encodeId=23af125686965, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率, objectType=article, longId=221742, objectId=0372221e4226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0372221e4226, replyNumber=0, likeNumber=108, createdTime=2021-12-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0372221e4226, moduleTitle=Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0372221e4226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256867, encodeId=f9af125686e66, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Gut Microbes：实锤！“癌症之王”胰腺癌生存率为啥那么低？消化道细菌是“帮凶”！, objectType=article, longId=221312, objectId=a5e62213128d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5e62213128d, replyNumber=0, likeNumber=96, createdTime=2021-12-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5e62213128d, moduleTitle=Gut Microbes：实锤！“癌症之王”胰腺癌生存率为啥那么低？消化道细菌是“帮凶”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5e62213128d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256866, encodeId=98d8125686647, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=eLife：小黑痣是怎么癌变成黑色素瘤的？与周围皮肤中的环境信号有关反应，提高移植细胞的生存率, objectType=article, longId=221202, objectId=9a872212023e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a872212023e, replyNumber=0, likeNumber=120, createdTime=2021-11-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a872212023e, moduleTitle=eLife：小黑痣是怎么癌变成黑色素瘤的？与周围皮肤中的环境信号有关反应，提高移植细胞的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a872212023e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256865, encodeId=77f0125686548, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=221034, objectId=5e2522103406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e2522103406, replyNumber=0, likeNumber=106, createdTime=2021-11-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e2522103406, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e2522103406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256864, encodeId=9c88125686499, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, objectType=article, longId=220763, objectId=d703220e63d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d703220e63d2, replyNumber=0, likeNumber=150, createdTime=2021-11-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d703220e63d2, moduleTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d703220e63d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256863, encodeId=3034125686343, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查, objectType=article, longId=220346, objectId=b32c22034692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32c22034692, replyNumber=0, likeNumber=0, createdTime=2021-11-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32c22034692, moduleTitle=AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b32c22034692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256862, encodeId=26241256862cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？, objectType=article, longId=219904, objectId=f023219904e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f023219904e8, replyNumber=0, likeNumber=77, createdTime=2021-11-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f023219904e8, moduleTitle=Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f023219904e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256861, encodeId=1c781256861bb, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, objectType=article, longId=219773, objectId=a363219e736a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a363219e736a, replyNumber=0, likeNumber=79, createdTime=2021-11-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a363219e736a, moduleTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a363219e736a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256860, encodeId=06141256860ea, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, objectType=article, longId=219464, objectId=7756219464f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7756219464f4, replyNumber=0, likeNumber=66, createdTime=2021-10-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7756219464f4, moduleTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7756219464f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256859, encodeId=3e6112568595a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？, objectType=article, longId=218837, objectId=989a21883e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=989a21883e0b, replyNumber=0, likeNumber=110, createdTime=2021-10-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=989a21883e0b, moduleTitle=J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=989a21883e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256858, encodeId=f1a81256858ad, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率, objectType=article, longId=218686, objectId=4c14218686ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c14218686ce, replyNumber=0, likeNumber=77, createdTime=2021-10-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c14218686ce, moduleTitle=Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c14218686ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256857, encodeId=1658125685e80, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！, objectType=article, longId=218413, objectId=284d218413e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=284d218413e6, replyNumber=0, likeNumber=105, createdTime=2021-10-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=284d218413e6, moduleTitle=EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=284d218413e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256856, encodeId=800c12568568a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响, objectType=article, longId=218176, objectId=66902181e63f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66902181e63f, replyNumber=0, likeNumber=157, createdTime=2021-10-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66902181e63f, moduleTitle=BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66902181e63f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256855, encodeId=9b141256855c3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验, objectType=article, longId=217971, objectId=9e3021e9717d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e3021e9717d, replyNumber=0, likeNumber=92, createdTime=2021-10-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e3021e9717d, moduleTitle=Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e3021e9717d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256854, encodeId=6ed812568541b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, objectType=article, longId=217649, objectId=f7b621e649bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b621e649bb, replyNumber=0, likeNumber=95, createdTime=2021-09-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b621e649bb, moduleTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b621e649bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256853, encodeId=2fc11256853da, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：多发性硬化症患者结直肠癌生存率, objectType=article, longId=217263, objectId=19d921e2630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19d921e2630a, replyNumber=0, likeNumber=106, createdTime=2021-09-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19d921e2630a, moduleTitle=Neurology：多发性硬化症患者结直肠癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19d921e2630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Dig Liver Dis：血清胆固醇水平可以预测接受经颈静脉肝内门体分流术的肝硬化患者的无移植生存率

2021-12-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ARD: 法国系统性红斑狼疮住院患者COVID-19相关器官衰竭后的生存率：一项全国性研究

2021-12-21

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：多发性硬化症患者结直肠癌生存率

2021-12-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Thromb Haemost：噬血细胞性淋巴组织细胞增生症成人出血和血栓栓塞发生率及其对总生存率的影响

2021-12-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率

2021-12-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Gut Microbes：实锤！“癌症之王”胰腺癌生存率为啥那么低？消化道细菌是“帮凶”！

2021-12-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

eLife：小黑痣是怎么癌变成黑色素瘤的？与周围皮肤中的环境信号有关反应，提高移植细胞的生存率

2021-11-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2021-11-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关

2021-11-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查

2021-11-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？

2021-11-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关

2021-11-05

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究

2021-10-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？

2021-10-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率

2021-10-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！

2021-10-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响

2021-10-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验

2021-10-02

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响

2021-09-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：多发性硬化症患者结直肠癌生存率

2021-09-19

科室
- - 订阅+
  - 更多科室
工具
服务